Andrew Dionson

Andrew Dionson is a Regulatory Affairs Specialist at OASIS Medical, with a background in consulting and regulatory affairs within the biotechnology and medical sectors. Previous experience includes serving as a Graduate Student Consultant at Amgen, where Andrew designed optimization models for clinical supply chains and coordinated stakeholder engagement. Andrew also gained experience as a Regulatory Affairs Intern at MicroVention-Terumo, assisting with international submissions and regulatory compliance. Earlier roles included analyzing market potential for new vaccine technologies at Karma Biotechnologies and managing a scribe support program at City of Hope. Andrew's academic qualifications include a Master's in Business and Science from Keck Graduate Institute and a degree in Microbiology, Immunology, and Molecular Genetics from UCLA.